1
ELI LILLY & CO
COM
LLY
LLY
29,821
$35.8m9.62%
9.62%
Reduced Shares held: Q3 2025 37.2k, Q4 2025 31.1k, Q1 2026 39.7k, Q2 2026 29.8k
-9.9k
-9,901
-24.9%
2
MERCK & CO INC
COM
MRK
MRK
189,357
$24.3m6.55%
6.55%
Added Shares held: Q3 2025 160.9k, Q4 2025 195.8k, Q1 2026 33.9k, Q2 2026 189.4k
+155.5k
+155,504
459.4%
3
JOHNSON & JOHNSON
COM
JNJ
JNJ
85,425
$21.7m5.84%
5.84%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 92.4k, Q2 2026 85.4k
-7.0k
-6,952
-7.5%
4
ABBVIE INC
COM
ABBV
ABBV
64,325
$16.2m4.35%
4.35%
Reduced Shares held: Q3 2025 92.1k, Q4 2025 108.2k, Q1 2026 108.2k, Q2 2026 64.3k
-43.9k
-43,856
-40.5%
5
CVS HEALTH CORP
COM
CVS
CVS
146,102
$15.1m4.07%
4.07%
Added Shares held: Q3 2025 0, Q4 2025 106.5k, Q1 2026 23.8k, Q2 2026 146.1k
+122.3k
+122,329
514.6%
6
THERMO FISHER SCIENTIFIC INC
COM
TMO
TMO
27,859
$14.0m3.76%
3.76%
Added Shares held: Q3 2025 27.1k, Q4 2025 29.9k, Q1 2026 23.0k, Q2 2026 27.9k
+4.9k
+4,873
21.2%
7
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
73,077
$13.7m3.68%
3.68%
Reduced Shares held: Q3 2025 85.4k, Q4 2025 90.2k, Q1 2026 617.2k, Q2 2026 73.1k
-544.2k
-544,168
-88.2%
8
BIOGEN INC
COM
BIIB
BIIB
62,781
$13.6m3.65%
3.65%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 62.8k
9
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
72,898
$12.3m3.31%
3.31%
Reduced Shares held: Q3 2025 102.6k, Q4 2025 94.8k, Q1 2026 89.7k, Q2 2026 72.9k
-16.8k
-16,787
-18.7%
10
MIRUM PHARMACEUTICALS INC
COM
MIRM
MIRM
100,807
$11.8m3.17%
3.17%
Reduced Shares held: Q3 2025 93.6k, Q4 2025 89.7k, Q1 2026 195.8k, Q2 2026 100.8k
-95.0k
-94,961
-48.5%
11
ALKERMES PLC
SHS
ALKS
ALKS
213,329
$11.2m3.01%
3.01%
Reduced Shares held: Q3 2025 252.9k, Q4 2025 242.5k, Q1 2026 242.5k, Q2 2026 213.3k
-29.1k
-29,144
-12.0%
12
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
137,131
$10.9m2.93%
2.93%
Added Shares held: Q3 2025 0, Q4 2025 92.4k, Q1 2026 27.9k, Q2 2026 137.1k
+109.3k
+109,258
392.0%
13
BEIGENE LTD
SPONSORED ADR
ONC
ONC
35,180
$10.0m2.70%
2.70%
Reduced Shares held: Q3 2025 30.3k, Q4 2025 40.4k, Q1 2026 41.7k, Q2 2026 35.2k
-6.5k
-6,537
-15.7%
14
INTUITIVE SURGICAL INC
COM NEW
ISRG
ISRG
24,656
$9.8m2.64%
2.64%
Reduced Shares held: Q3 2025 19.7k, Q4 2025 22.3k, Q1 2026 70.9k, Q2 2026 24.7k
-46.2k
-46,195
-65.2%
15
STRYKER CORPORATION
COM
SYK
SYK
30,283
$9.5m2.57%
2.57%
Added Shares held: Q3 2025 22.8k, Q4 2025 26.8k, Q1 2026 26.8k, Q2 2026 30.3k
+3.4k
+3,448
12.8%
16
VERTEX PHARMACEUTICALS INC
COM
VRTX
VRTX
19,131
$9.5m2.56%
2.56%
Reduced Shares held: Q3 2025 17.8k, Q4 2025 23.0k, Q1 2026 23.0k, Q2 2026 19.1k
-3.9k
-3,853
-16.8%
17
EDWARDS LIFESCIENCES CORP
COM
EW
EW
103,230
$9.3m2.51%
2.51%
Reduced Shares held: Q3 2025 65.7k, Q4 2025 0, Q1 2026 106.5k, Q2 2026 103.2k
-3.3k
-3,288
-3.1%
18
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
124,707
$9.3m2.50%
2.50%
Added Shares held: Q3 2025 174.7k, Q4 2025 141.3k, Q1 2026 111.4k, Q2 2026 124.7k
+13.3k
+13,344
12.0%
19
KRYSTAL BIOTECH INC
COM
KRYS
KRYS
24,019
$8.9m2.40%
2.40%
Reduced Shares held: Q3 2025 42.2k, Q4 2025 33.9k, Q1 2026 37.6k, Q2 2026 24.0k
-13.6k
-13,560
-36.1%
20
CENCORA INC
COM
COR
COR
31,126
$8.8m2.37%
2.37%
Added Shares held: Q3 2025 28.6k, Q4 2025 23.8k, Q1 2026 23.5k, Q2 2026 31.1k
+7.7k
+7,656
32.6%
21
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
NAMS
NAMS
248,848
$8.4m2.27%
2.27%
Added Shares held: Q3 2025 193.6k, Q4 2025 197.0k, Q1 2026 94.8k, Q2 2026 248.8k
+154.1k
+154,052
162.5%
22
ABIVAX SA
SPONSORED ADS
ABVX
ABVX
58,170
$7.8m2.09%
2.09%
Added Shares held: Q3 2025 0, Q4 2025 31.6k, Q1 2026 31.6k, Q2 2026 58.2k
+26.6k
+26,580
84.1%
23
INCYTE CORP
COM
INCY
INCY
56,953
$6.5m1.74%
1.74%
Added Shares held: Q3 2025 0, Q4 2025 70.9k, Q1 2026 50.8k, Q2 2026 57.0k
+6.2k
+6,157
12.1%
24
IRHYTHM TECHNOLOGIES INC
COM
IRTC
IRTC
54,102
$6.4m1.73%
1.73%
Added Shares held: Q3 2025 30.0k, Q4 2025 37.6k, Q1 2026 22.3k, Q2 2026 54.1k
+31.8k
+31,780
142.4%
25
BOSTON SCIENTIFIC CORP
COM
BSX
BSX
146,381
$6.2m1.68%
1.68%
Added Shares held: Q3 2025 86.7k, Q4 2025 108.7k, Q1 2026 40.4k, Q2 2026 146.4k
+105.9k
+105,949
262.0%
26
INSMED INC
COM PAR $.01
INSM
INSM
58,378
$6.2m1.67%
1.67%
Reduced Shares held: Q3 2025 0, Q4 2025 27.9k, Q1 2026 97.4k, Q2 2026 58.4k
-39.1k
-39,060
-40.1%
27
TANGO THERAPEUTICS INC
COM
TNGX
TNGX
198,557
$6.2m1.67%
1.67%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 29.9k, Q2 2026 198.6k
+168.6k
+168,642
563.7%
28
GILEAD SCIENCES INC
COM
GILD
GILD
46,142
$5.8m1.57%
1.57%
Reduced Shares held: Q3 2025 78.2k, Q4 2025 50.8k, Q1 2026 48.0k, Q2 2026 46.1k
-1.8k
-1,825
-3.8%
29
CARDINAL HEALTH INC
COM
CAH
CAH
23,630
$5.6m1.51%
1.51%
Reduced Shares held: Q3 2025 30.3k, Q4 2025 23.5k, Q1 2026 108.7k, Q2 2026 23.6k
-85.1k
-85,052
-78.3%
30
ORUKA THERAPEUTICS INC
COM
ORKA
ORKA
54,886
$5.2m1.41%
1.41%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 54.9k
31
SPYRE THERAPEUTICS INC
COM NEW
SYRE
SYRE
57,030
$5.1m1.36%
1.36%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 62.7k, Q2 2026 57.0k
-5.7k
-5,705
-9.1%
32
DEXCOM INC
COM
DXCM
DXCM
71,846
$4.8m1.30%
1.30%
Reduced Shares held: Q3 2025 50.9k, Q4 2025 39.7k, Q1 2026 584.3k, Q2 2026 71.8k
-512.5k
-512,486
-87.7%
33
BICARA THERAPEUTICS INC
COM
BCAX
BCAX
145,657
$4.3m1.16%
1.16%
Reduced Shares held: Q3 2025 203.8k, Q4 2025 111.4k, Q1 2026 1.2m, Q2 2026 145.7k
-1.0m
-1,023,977
-87.5%
34
IDEAYA BIOSCIENCES INC
COM
IDYA
IDYA
94,478
$3.5m0.95%
0.95%
Added Shares held: Q3 2025 0, Q4 2025 97.4k, Q1 2026 31.1k, Q2 2026 94.5k
+63.3k
+63,345
203.5%
35
CELCUITY INC
COM
CELC
CELC
33,313
$3.5m0.94%
0.94%
Reduced Shares held: Q3 2025 37.2k, Q4 2025 41.8k, Q1 2026 141.3k, Q2 2026 33.3k
-108.0k
-107,983
-76.4%
36
DISC MEDICINE INC
COM
IRON
IRON
43,682
$3.2m0.86%
0.86%
Reduced Shares held: Q3 2025 45.7k, Q4 2025 48.0k, Q1 2026 107.3k, Q2 2026 43.7k
-63.6k
-63,573
-59.3%
37
PYXIS ONCOLOGY INC
COMMON STOCK
PYXS
PYXS
966,459
$2.9m0.78%
0.78%
Added Shares held: Q3 2025 0, Q4 2025 617.2k, Q1 2026 197.0k, Q2 2026 966.5k
+769.4k
+769,423
390.5%
38
COMPASS THERAPEUTICS INC
COM
CMPX
CMPX
1,048,593
$2.3m0.62%
0.62%
Added Shares held: Q3 2025 0, Q4 2025 584.3k, Q1 2026 41.8k, Q2 2026 1.0m
+1.0m
+1,006,762
2406.7%
39
JADE BIOSCIENCES INC
COM NEW
JBIO
JBIO
88,556
$2.0m0.53%
0.53%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 88.6k